scholarly article | Q13442814 |
P50 | author | Chaok Seok | Q28914821 |
Taeyong Park | Q112312083 | ||
P2093 | author name string | Wonpil Im | |
Jumin Lee | |||
Min Sun Yeom | |||
Sang-Jun Park | |||
Yiwei Cao | |||
Tristan Croll | |||
Hyeonuk Woo | |||
Maham Tanveer | |||
Nathan R Kern | |||
Yeol Kyo Choi | |||
P2860 | cites work | CHARMM36m: an improved force field for folded and intrinsically disordered proteins | Q40299880 |
Lipid composition of viral envelope of three strains of influenza virus - not all viruses are created equal. | Q40961355 | ||
OpenMM 7: Rapid development of high performance algorithms for molecular dynamics. | Q41327186 | ||
Determination of alkali and halide monovalent ion parameters for use in explicitly solvated biomolecular simulations | Q41930764 | ||
Long-Time-Step Molecular Dynamics through Hydrogen Mass Repartitioning | Q46308001 | ||
Palmitoylation of the cysteine-rich endodomain of the SARS-coronavirus spike glycoprotein is important for spike-mediated cell fusion. | Q53585772 | ||
ISOLDE: a physically realistic environment for model building into low-resolution electron-density maps | Q57753884 | ||
CHARMM-GUI: a web-based graphical user interface for CHARMM | Q80900573 | ||
Canonical dynamics: Equilibrium phase-space distributions | Q21709091 | ||
CHARMM: the biomolecular simulation program | Q24658108 | ||
Glycan shield and epitope masking of a coronavirus spike protein observed by cryo-electron microscopy | Q27728036 | ||
VMD: visual molecular dynamics | Q27860554 | ||
Scalable molecular dynamics with NAMD | Q27860718 | ||
The Amber biomolecular simulation programs | Q27860745 | ||
Structural Basis for Plexin Activation and Regulation | Q28277024 | ||
Protein homology detection by HMM-HMM comparison | Q28292161 | ||
Update of the CHARMM all-atom additive force field for lipids: validation on six lipid types | Q29616710 | ||
Lipid14: The Amber Lipid Force Field. | Q30362297 | ||
Protein crystallography for non-crystallographers, or how to get the best (but not more) from published macromolecular structures. | Q30384774 | ||
Glycan Reader: automated sugar identification and simulation preparation for carbohydrates and glycoproteins | Q30405636 | ||
OpenMM 4: A Reusable, Extensible, Hardware Independent Library for High Performance Molecular Simulation | Q30415382 | ||
GalaxyTBM: template-based modeling by building a reliable core and refining unreliable local regions | Q30420248 | ||
Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains | Q30845557 | ||
Automated builder and database of protein/membrane complexes for molecular dynamics simulations | Q33298604 | ||
Glycan Reader is Improved to Recognize Most Sugar Types and Chemical Modifications in the Protein Data Bank. | Q33459363 | ||
Additive empirical force field for hexopyranose monosaccharides | Q33899141 | ||
CHARMM-GUI Membrane Builder toward realistic biological membrane simulations | Q34195752 | ||
The HIV lipidome: a raft with an unusual composition | Q34479764 | ||
GLYCAM06: a generalizable biomolecular force field. Carbohydrates | Q34686342 | ||
The FALC-Loop web server for protein loop modeling | Q35075600 | ||
GENESIS: a hybrid-parallel and multi-scale molecular dynamics simulator with enhanced sampling algorithms for biomolecular and cellular simulations. | Q36417390 | ||
CHARMM-GUI Input Generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM Simulations Using the CHARMM36 Additive Force Field | Q36461179 | ||
CHARMM-GUI PDB manipulator for advanced modeling and simulations of proteins containing nonstandard residues. | Q36539936 | ||
Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone φ, ψ and side-chain χ(1) and χ(2) dihedral angles | Q36546184 | ||
ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB. | Q36766916 | ||
GalaxyRefineComplex: Refinement of protein-protein complex model structures driven by interface repacking | Q37184982 | ||
CHARMM-GUI Membrane Builder for mixed bilayers and its application to yeast membranes | Q37263413 | ||
Structural basis for membrane anchoring of HIV-1 envelope spike | Q37376640 | ||
UCSF ChimeraX: Meeting Modern Challenges in Visualization and Analysis. | Q38677893 | ||
Solution structure of the severe acute respiratory syndrome-coronavirus heptad repeat 2 domain in the prefusion state | Q82685553 | ||
Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2 | Q87726414 | ||
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein | Q87973551 | ||
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation | Q89108866 | ||
Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses | Q89866691 | ||
CHARMM-GUI Membrane Builder for Complex Biological Membrane Simulations with Glycolipids and Lipoglycans | Q90331251 | ||
Structural basis of receptor recognition by SARS-CoV-2 | Q90738246 | ||
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor | Q90738260 | ||
CHARMM-GUI Glycan Modeler for modeling and simulation of carbohydrates and glycoconjugates | Q91250843 | ||
Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2 | Q91807337 | ||
GalaxyTongDock: Symmetric and asymmetric ab initio protein-protein docking web server with improved energy parameters | Q92583245 | ||
The PSIPRED Protein Analysis Workbench: 20 years on | Q93101309 | ||
A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells | Q94500293 | ||
Deducing the N- and O- glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2 | Q94503955 | ||
Site-specific glycan analysis of the SARS-CoV-2 spike | Q94520441 | ||
P921 | main subject | SARS-CoV-2 | Q82069695 |
P577 | publication date | 2020-05-21 | |
P1476 | title | Modeling and Simulation of a Fully-glycosylated Full-length SARS-CoV-2 Spike Protein in a Viral Membrane |
Q99355456 | Are open-source approaches the most efficient way forward for COVID-19 drug discovery? | cites work | P2860 |
Search more.